Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Siemens nets U.K. PET/MR install

The UKs first Biograph mMR, a hybrid molecular MR system from Siemens Healthcare, has been delivered to the University College Hospital (UCH) Macmillan Cancer Centre in London.

AAMI releases new device-related, adverse-event terminology

To help report device-related adverse events with greater accuracy and consistency, the Association for the Advancement of Medical Instrumentation (AAMI) has put together a glossary of terms and posted it for free on its website.

Deadline Approaches: How Nuclear Labs Prep for Accreditation

Independent nuclear laboratories are under a mandate to achieve accreditation by Jan. 1, 2012, to continue receiving Medicare reimbursement. While maneuvering the varied accreditation processes requires practice management savvycausing some practices to prolong the processthe impending deadline is approaching fast.

Promise of better tracking, with more clarity

While imaging has become firmly entrenched in the patient care cycle, preclinical imaging is revealing the promise of enhanced methods of tracking varied conditions with even more clarity through the use of new tracers.

Study: Dramatic rise in sports-related knee injuries among kids

Over the past 12 years, the number of children with tears of the anterior cruciate ligament and meniscus have increased dramatically, according to orthopedic surgeons from The Childrens Hospital of Philadelphia who presented their findings Oct. 16 at the American Academy of Pediatrics annual meeting in Boston.

HBMA: Differing definitions of 5010 readiness plagues process

The Healthcare Billing & Management Association (HBMA) has developed standard definitions for 5010 readiness for providers, software vendors, clearinghouses and health plans in response to the inconsistency of definitions found between each entity. The association shared these definitions with the Centers for Medicare & Medicaid Services in a letter dated Oct. 10.

JNM: 89Zr-7E11 for immuno-PET can monitor tumor therapy response

89Zr-desferrioxamine B-7E11 displays high tumor-to-background tissue contrast in immuno-PET and can be used as a tool to monitor and quantify with high specificity tumor response in prostate-specific membrane antigen (PSMA)-positive prostate cancer, according to research published in the October issue of the Journal of Nuclear Medicine.

JNM: 123I-MIBG SPECT may stratify risk for cardiomyopathy

In patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), an impairment of adrenergic innervation independent of the underlying genotype is associated with a higher incidence for future recurrences of ventricular tachyarrhythmias, which may suggest a potential role of 123I-MIBG SPECT for individualized risk stratification in ARVC patients and asymptomatic PKP-2 mutation carriers alike, according to a study published in this months Journal of Nuclear Medicine.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.